NOVO NORDISK A/S
Patent Owner
Stats
- 605 US PATENTS IN FORCE
- 76 US APPLICATIONS PENDING
- Mar 20, 2018 most recent publication
Details
- 605 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 68,661 Total Citation Count
- May 07, 1981 Earliest Filing
- 1,164 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0000,742 Pharmaceutical Composition for Oral Insulin Administration Comprising a Tablet Core and a Polyvinyl Alcohol CoatingJan 29, 15Jan 04, 18[A61K]
2017/0361,029 AN INJECTION NEEDLE ASSEMBLY FOR AN INJECTION DEVICE AND AN INJECTION DEVICE COMPRISING SUCH ASSEMBLYJan 22, 16Dec 21, 17[A61M]
2017/0348,491 HANDHELD SPRING DRIVEN INJECTION DEVICE WITH FORCE REGULATIONJan 06, 16Dec 07, 17[A61M]
2017/0340,808 Kit Comprising a Medical Accessory Device and a Dummy UnitJan 14, 16Nov 30, 17[G09B, A61M]
2017/0338,864 A Wireless Data Communication Module for Drug Injection DevicesJan 08, 16Nov 23, 17[H04B, H01Q, A61M]
2017/0326,302 Drug Injection Device with Visual End-Of-Contents Indicator SystemJan 08, 16Nov 16, 17[A61M]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9896513 Antibodies capable of specifically binding two epitopes on tissue factor pathway inhibitorMar 14, 14Feb 20, 18[A61K, C12P, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0334,971 Alpha-1-Antitrypsin (A1AT) Fusion Proteins and Uses ThereofAbandonedDec 22, 15Nov 23, 17[A61K, C07K]
2017/0020,992 Factor VIII Molecules with Reduced VWF BindingAbandonedOct 07, 16Jan 26, 17[A61K, C07K]
2017/0007,712 GLYCOPEGYLATION METHODS AND PROTEINS/PEPTIDES PRODUCED BY THE METHODSAbandonedAug 01, 16Jan 12, 17[A61K, C12N, C07K]
2017/0008,928 NOVEL PEPTIDES AND PEPTIDE DERIVATIVES AND USES THEREOFAbandonedJul 06, 16Jan 12, 17[A61K, C07K]
2016/0297,892 Novel Methods and Antibodies for Treating CoagulapathyAbandonedNov 07, 14Oct 13, 16[C07K]
2016/0207,977 Compounds Suitable for Treatment of HaemophiliaAbandonedJun 10, 14Jul 21, 16[A61K, C07K]
2016/0200,795 FACTOR VIII: REMODELING AND GLYCOCONJUGATION OF FACTOR VIIIAbandonedDec 18, 15Jul 14, 16[A61K, C07K]
2016/0193,154 Pharmaceutical Composition for Oral Insulin Administration Comprising a Tablet Core and an Anionic Copolymer CoatingAbandonedJul 11, 14Jul 07, 16[A61K]
2016/0193,353 FACTOR VIII: REMODELING AND GLYCOCONJUGATION OF FACTOR VIIIAbandonedMar 16, 16Jul 07, 16[A61K]
2016/0136,246 Novel Uses of GLP-1 Receptor Agonists in Patients Treated with Insulin and/or Suffering from Type 1 DiabetesAbandonedJun 23, 14May 19, 16[A61K]
2016/0106,814 Novel Oral Pharmaceutical Composition for Treatment of DiabetesAbandonedMay 30, 14Apr 21, 16[A61K]
2015/0376,262 Factor VIII Molecules With Reduced VWF BindingAbandonedSep 11, 15Dec 31, 15[A61K, C07K]
2015/0344,540 NOVEL GLP-1 RECEPTOR AGONISTS WITH CHOLESTEROL EFFLUX ACTIVITYAbandonedDec 19, 13Dec 03, 15[C07K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
